Patents by Inventor Steven A. Nanda

Steven A. Nanda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7531356
    Abstract: The DNA sequences of human and rat CRF2? receptor promoters are disclosed. Certain functional fragments of the human CRF2? receptor promoter are also disclosed. Further disclosed are a method of identifying functional fragments of human and rat CRF2? receptor promoters and a method of identifying agents that can alter the activity of the human or rat CRF2? receptor promoter.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: May 12, 2009
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ned H. Kalin, Patrick H. Roseboom, Charles F. Landry, Steven A. Nanda
  • Publication number: 20080124315
    Abstract: A method of treating a patient is disclosed. In one embodiment, the method comprises the step of reducing the amount of mRNA encoding corticotropin-releasing factor receptor, wherein a portion of the mRNA encoding corticotropin-releasing factor receptor is destroyed and wherein the amount of corticotrophin releasing factor receptor is reduced.
    Type: Application
    Filed: July 18, 2006
    Publication date: May 29, 2008
    Inventors: Steven A. Nanda, Vaishali P. Bakshi, Patrick H. Roseboom, Ned H. Kalin
  • Patent number: 7122650
    Abstract: Various human corticotropin-releasing factor binding protein promoter sequences are disclosed. Nucleic acids and host cells that contain the promoter sequences are also disclosed. Further disclosed are various methods involving the use of these sequences.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: October 17, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Patrick H. Roseboom, Ned H. Kalin, Steven A. Nanda
  • Patent number: 7071323
    Abstract: The DNA sequences of human and rat CRF2? receptor promoters are disclosed. Certain functional fragments of the human CRF2? receptor promoter are also disclosed. Further disclosed are a method of identifying functional fragments of human and rat CRF2? receptor promoters and a method of identifying agents that can alter the activity of the human or rat CRF2? receptor promoter.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: July 4, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ned H. Kalin, Patrick H. Roseboom, Charles F. Landry, Steven A. Nanda
  • Publication number: 20040132065
    Abstract: Various human corticotropin-releasing factor binding protein promoter sequences are disclosed. Nucleic acids and host cells that contain the promoter sequences are also disclosed. Further disclosed are various methods involving the use of these sequences.
    Type: Application
    Filed: October 1, 2003
    Publication date: July 8, 2004
    Inventors: Patrick H. Roseboom, Ned H. Kalin, Steven A. Nanda
  • Publication number: 20030110521
    Abstract: The DNA sequences of human and rat CRF2&agr; receptor promoters are disclosed. Certain functional fragments of the human CRF2&agr; receptor promoter are also disclosed. Further disclosed are a method of identifying functional fragments of human and rat CRF2&agr; receptor promoters and a method of identifying agents that can alter the activity of the human or rat CRF2&agr; receptor promoter.
    Type: Application
    Filed: November 12, 2002
    Publication date: June 12, 2003
    Inventors: Ned H. Kalin, Patrick H. Roseboom, Charles F. Landry, Steven A. Nanda
  • Publication number: 20020032912
    Abstract: A method for identifying agents that alter the activity of the promoter region of CRF2&agr; receptor is disclosed. In one embodiment, the method comprises the steps of (a) obtaining a cell line or organism, wherein the cell line or organism comprises a nucleic acid sequence encoding a promoter sequence of a heterologous CRF2&agr; receptor operably attached to a reporter gene and (b) introducing a test agent into the cell or transgenic animal and evaluating the expression of the reporter gene product compared to a control cell line or transgenic animal wherein the agent has not been introduced into the cell line or transgenic animal.
    Type: Application
    Filed: April 30, 2001
    Publication date: March 14, 2002
    Inventors: Ned H. Kalin, Patrick H. Roseboom, Charles F. Landry, Steven A. Nanda